Skip to main content

Advertisement

SpringerLink
Log in

Pathogenesis of ANCA-Associated Vasculitis, an Update

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Clinical observations, including a report of neonatal vasculitis occurring in a child born from a mother with anti-neutrophil cytoplasmic antibody directed to myeloperoxidase (MPO-ANCA)-associated vasculitis, suggest a pathogenic role for ANCA. Such a role is supported by in vitro experimental data showing that ANCA can activate primed neutrophils to the production of reactive oxygen species and lytic enzymes resulting in lysis of endothelial cells. An interplay between neutrophils, the alternative pathway of complement, and MPO-ANCA resulting in systemic vasculitis including necrotizing glomerulonephritis has clearly been demonstrated in animal models. An in vivo pathogenic role of ANCA directed to proteinase 3 (PR3-ANCA) has, however, not been substantiated. In PR3-ANCA-associated vasculitis, granulomatous inflammation points to involvement of cell-mediated immunity. In vitro studies, indeed, suggest that PR3-specific Th17 CD4-positive lymphocytes are operative in lesion development. The triggering role of microbial factors is becoming more clear. In particular Staphylococcus aureus carriage and infection with Gram-negative bacteria could contribute to induction and persistence of ANCA-associated vasculitis (AAV). Insight into the pathogenic pathways involved in AAV have opened and will further open new ways to targeted treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chen M, Kallenberg CGM (2010) ANCA-associated vasculitides—advances in pathogenesis and treatment. Nat Rev Rheumatol 6:653–664

    Article  PubMed  CAS  Google Scholar 

  2. Kallenberg CGM (2005) Churg–Strauss syndrome: just one disease entity? (Editorial). Arthritis Rheum 52:2589–2593

    Article  PubMed  Google Scholar 

  3. van der Woude FJ, Rasmussen N, Lobatto S et al (1985) Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener’s Granulomatosis. Lancet ii:425–429

    Article  Google Scholar 

  4. Cohen Tervaert JW, van der Woude FJ, Fauci AS et al (1989) Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461–2465

    Article  Google Scholar 

  5. Cohen Tervaert JW, Huitema MG, Hené RJ et al (1990) Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709–711

    Article  Google Scholar 

  6. Boomsma MM, Stegeman CA, van der Leij MJ et al (2000) Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43:2025–2033

    Article  PubMed  CAS  Google Scholar 

  7. Finkielman JD, Merkel PA, Schroeder D et al (2007) Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 147:611–619

    PubMed  Google Scholar 

  8. Stegeman CA, Cohen Tervaert JW, Sluiter WJ et al (1994) Association of nasal carriage of Staphylococcus aureus and higher relapse in Wegener's granulomatosis. Ann Intern Med 120:12–17

    PubMed  CAS  Google Scholar 

  9. Sanders JS, Huitema MG, Kallenberg CG, Stegeman CA (2006) Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology 45:724–729

    Article  PubMed  CAS  Google Scholar 

  10. Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232

    Article  PubMed  CAS  Google Scholar 

  11. Jones RB, Cohen Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211–220

    Article  PubMed  CAS  Google Scholar 

  12. Cartin-Ceba R, Golbin J, Keogh KA et al (2010) Ritixumab for remission induction and maintenance in ANCA-associated vasculitis: a single-center ten-year experience in 108 patients. Arthritis Rheum 62(S10):S283–S284

    Google Scholar 

  13. Bansal PJ, Tobin MC (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93:398–401

    Article  PubMed  Google Scholar 

  14. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115–4119

    Article  PubMed  CAS  Google Scholar 

  15. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC (1991) Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50:539–546

    PubMed  CAS  Google Scholar 

  16. Mulder AHL, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 98:270–278

    Article  PubMed  CAS  Google Scholar 

  17. Kocher M, Edberg JC, Fleit HB, Kimberly RP (1998) Antineutrophil cytoplasmic antibodies preferentially engage FcγRIIIb on human neutrophils. J Immunol 161:6909–6914

    PubMed  CAS  Google Scholar 

  18. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ (1995) Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86:3189–3195

    PubMed  CAS  Google Scholar 

  19. Radford DJ, Savage CO, Nash GB (2000) Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum 43:1337–1345

    Article  PubMed  CAS  Google Scholar 

  20. Ewert BH, Jennette JC, Falk RJ (1992) Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41:375–383

    Article  PubMed  CAS  Google Scholar 

  21. Williams JM, Pettitt TR, Powell W, Grove J, Savage CO, Wakelam MJ (2007) Antineutrophil cytoplasm antibody-stimulated neutrophil adhesion depends on diacylglycerol kinase-catalyzed phosphatidic acid formation. J Am Soc Nephrol 18:1112–1120

    Article  PubMed  CAS  Google Scholar 

  22. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170:52–64

    Article  PubMed  CAS  Google Scholar 

  23. Xing CQ, Chen M, Liu G et al (2009) Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29:282–291

    Article  PubMed  CAS  Google Scholar 

  24. Brouwer E, Huitema MG, Klok PA, Cohen Tervaert JW, Weening JJ, Kallenberg CGM (1993) Anti-myeloperoxidase associated proliferative glomerulonephritis: an animal model. J Exp Med 177:905–914

    Article  PubMed  CAS  Google Scholar 

  25. Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, Kallenberg CGM (1996) Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 149:1695–1706

    PubMed  CAS  Google Scholar 

  26. Xiao H, Heeringa P, Hu P et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955–963

    PubMed  CAS  Google Scholar 

  27. Huugen D, Xiao H, van Esch A et al (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167:47–58

    Article  PubMed  CAS  Google Scholar 

  28. Xiao H, Heeringa P, Liu Z et al (2005) The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167:39–45

    Article  PubMed  CAS  Google Scholar 

  29. Schreiber A, Xiao H, Falk RJ, Jennette JC (2006) Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. J Am Soc Nephrol 17:3355–3364

    Article  PubMed  Google Scholar 

  30. Xiao H, Schreiber A, Heeringa P et al (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170:52–64

    Article  PubMed  CAS  Google Scholar 

  31. Huugen D, van Esch A, Xiao H et al (2007) Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71:646–654

    Article  PubMed  CAS  Google Scholar 

  32. van Timmeren MM, van der Veen BS, Stegeman CA et al (2010) IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 21:1103–1114

    Article  PubMed  Google Scholar 

  33. Little MA, Smyth CL, Yadav R et al (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106:2050–2058

    Article  PubMed  CAS  Google Scholar 

  34. Pfister H, Ollert M, Frohlich LF et al (2004) Antineutrophil cytoplasmic autoantibodies against the murine homologe of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104:1411–1418

    Article  PubMed  CAS  Google Scholar 

  35. van der Geld YM, Hellmark T, Selga D et al (2007) Rats and mice immunized with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes. Ann Rheum Dis 66:679–682

    Google Scholar 

  36. Franssen CFM, Stegeman CA, Kallenberg CGM et al (2000) Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 57:2195–2206

    Article  PubMed  CAS  Google Scholar 

  37. Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG (2006) Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 70:938–947

    Article  PubMed  CAS  Google Scholar 

  38. Abdulahad WH, Kallenberg CG, Limburg PC, Stegeman CA (2009) Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 60:2830–2838

    Article  PubMed  CAS  Google Scholar 

  39. Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M (2010) Urinary T cells in active lupus nephritis show an effector memory phenotype. Ann Rheum Dis 69:2034–2041

    Article  PubMed  Google Scholar 

  40. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG (2008) Skewed distribution of Th17 lymphocytes in patients with Wegener’s granulomatosis in remission. Arthritis Rheum 58:2196–2205

    Article  PubMed  Google Scholar 

  41. Hemdan NY, Birkenmeier G, Wichmann G et al (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785–792

    Article  PubMed  CAS  Google Scholar 

  42. Laan M, Cui ZH, Hoshino H et al (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347–2352

    PubMed  CAS  Google Scholar 

  43. Nogueira E, Hamour S, Sawant D et al (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25:2209–2217

    Article  PubMed  CAS  Google Scholar 

  44. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG (2007) Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 56:2080–2091

    Article  PubMed  CAS  Google Scholar 

  45. Abdulahad WH, Boots AM, Kallenberg CG (2010) FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells. Rheumatology (Oxford) doi:10.1093/rheumatology/keq328

  46. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335:16–20

    Article  PubMed  CAS  Google Scholar 

  47. Popa ER, Stegeman CA, Bos NA, Kallenberg CGM, Tervaert JWC (2003) Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol 132:496–504

    Article  PubMed  CAS  Google Scholar 

  48. Popa ER, Stegeman CA, Abdulahad WH et al (2007) Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatol Oxf 46:1029–1033

    Article  CAS  Google Scholar 

  49. Voswinkel J, Mueller A, Kraemer JA et al (2006) B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 65:859–864

    Article  PubMed  CAS  Google Scholar 

  50. Voswinkel J, Assmann G, Held G et al (2008) Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions. Clin Exp Immunol 154:339–345

    Article  PubMed  CAS  Google Scholar 

  51. Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CG, Heeringa P (2010) Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford) doi:10.1093/rheumatology/keq375

  52. Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088–1096

    Article  PubMed  CAS  Google Scholar 

  53. Abdulahad WH, Stegeman CA, Kallenberg CG (2009) Review article: the role of CD4(+) T cells in ANCA-associated vasculitis. Nephrology 14:26–32

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology and Clinical Immunology, AA21, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands

    Cees G. M. Kallenberg

Authors
  1. Cees G. M. Kallenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cees G. M. Kallenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kallenberg, C.G.M. Pathogenesis of ANCA-Associated Vasculitis, an Update. Clinic Rev Allerg Immunol 41, 224–231 (2011). https://doi.org/10.1007/s12016-011-8258-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-011-8258-y

Keywords

Search

Navigation